Gastrointestinal diseases, such as Clostridium Difficile infection (CDI) are dangerous and serious. They affect thousands of Hong Kong residents, and hundreds of thousands of residents in other Asian cities. These patients are subjected to painful daily symptoms.
Scientists have uncovered the use of fecal microbiota transfer (FMT) as the most effective tool to treat recurrent CDI, and useful against other GI diseases. In this procedure, bacteria which have been derived from the fecal matter of a screened healthy donor is transplanted into a patient’s colon.
There is a wealth of information available online about FMT, most often referred to as Fecal Microbiota Transfer. Not all of the information is accurate or safe, so please use caution in your reading.
Safety is the highest priority. In order to learn more about our safety screening and handling protocols, please visit our Quality and Safety page.
If you are considering a HMT therapy as a patient, please consult with your doctor to determine if this is the right treatment for you. Currently, HMT to treat CDI is a well-established therapeutic application. For diseases other than CDI, there is ongoing research as to the safety and efficacy of HMT.
Mayo Clinic overview of FMT